Invest Now
Samco Star Rating Ads

Price Performance

  • Day's Low
  • ₹71.7
  • Day's High
  • ₹74.5
₹ 72.25
  • 52-w low
  • ₹50.65
  • 52-w high
  • ₹93.95
72.25
  • Day's open
    ₹74.5
  • Previous close
    ₹73.349998
  • VWAP
    ₹72.3
  • Lower price band
    ₹69.7
  • Upper price band
    ₹77

Today's Market Action

The last traded share price of Krebs Biochemicals Industries Ltd was 72.25 down by -1.50% on the NSE. Its last traded stock price on BSE was 71.82 down by -2.06%. The total volume of shares on NSE and BSE combined was 8,494 shares. Its total combined turnover was Rs 0.06 crores.

Medium and Long Term Market Action

Krebs Biochemicals Industries Ltd hit a 52-week high of 93.95 on 07-11-2023 and a 52-week low of 50.65 on 29-03-2023. The stock price of Krebs Biochemicals Industries Ltd is down by -1% over the last one month. It is down by -7.31% over the last one year. Don't forget to check the full stock price history in the table below.

Fundamentals

  • Market Cap (Cr): 158

  • Book Value (₹):

  • Stock P/E:

  • Revenue (Cr):

  • Total Debt (Cr):

  • Face Value (₹):

  • Roce (%):

  • ROE (%):

  • Earnings (Cr):

  • Promoter’s Holdings (%):

  • EPS (₹):

  • Debt to Equity:

  • Dividend Yield (%):

  • Cash (Cr):

Mutual fund holdings and trends

FUND NAME Quantity Monthly Change (Qty)

Shareholding Pattern

Similar Stocks

Company Price Market Cap (Cr) P/E

About

Data not available.

FAQ's

How to Buy Krebs Biochemicals Industries Ltd Share?

What is the Share Price of Krebs Biochemicals Industries Ltd?

What is the Market Cap of Krebs Biochemicals Industries Ltd?

(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Net Profit)

Standalone Financial Performace In Graph(Net Profit)

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Net Profit)

Standalone Financial Performace In Graph(Net Profit)

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Cash Flow)

Standalone Financial Performace In Graph(Cash Flow)

Pros

  • High Shareholder Pedigree
    The company has a solid long term shareholder base which reduces the degree of speculation and volatility in the stock. This works well for long term equity shareholders.

Cons

  • Low Sustainable RoE
    The company's sustainable return on equity is lower than the expected cost of capital which implies that the underlying business will destruct value over a period of time due to it's inability to generate superior returns on capital.
  • Low Return on Capital Employed
    The company is unable to generate sufficient return on capital employed which impairs it's ability to generate high return for shareholders after accounting for taxes, interest and other non-equity stakeholders.
  • Negative operating earnings and interest coverage
    The company has a negative operating earnings and a negative Interest coverage ratio of -5.33 times which implies that the company has no operating earnings to pay for interest which is currently being paid out of capital and/or other income. This is extremely negative for shareholders.
  • Low Pricing Power & High Competition
    The business has extremely low pricing power and is vulnerable to competitive pressure which can significantly impact shareholder returns.
  • Capital Intensive Business
    The company operates an extremely capital intensive business with a low Asset turnover ratio of 0.32. A low asset turnover ratio negatively impacts RoE and reduces shareholder returns. Also due to the capital intensive nature of business, growth of the business would need to be funded either via increasing borrowings or diluting shareholders, both of which shall negatively impact shareholder value and returns.
  • Negative Equity
    The company has a negative debt to equity ratio of -1.74. This implies that the underlying equity value of the business is 0 and the networth of equity holders is negative. For all practical purposes, this business is owned by it's debt holders leaving nothing for the equity holders.

Valuation Analysis

Margin of safety
(26/02/2024)
Stock Valuation
Green line
100
0%
0% People are bullish about Krebs Biochemicals Industries Ltd
0%
0 % People are bearish about Krebs Biochemicals Industries Ltd

What is your opinion about this Stock?

Historical Data

Samco Star Rating Ads

Krebs Biochemicals Industries Ltd

72.25 -1.10 (-1.50%)

Brokerage & Taxes at Samco

Brokerage & Taxes at Other traditional broker

Potential Brokerage Savings with Samco ₹ 49.62()

Top Gainers (NIFTY 50)

Stock Name Change %

    Top Losers (NIFTY 50)

    Stock Name Change %